1.2400
27-十一月-24 15:45:00
15 分钟延时
股票
+0.1300
+11.71%
今日范围
1.1300 - 1.3600
ISIN
N/A
来源
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 2月 2021 06:30:00 条件 Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 1月 2021 06:00:00 条件 Nasdaq GlobeNewswire